Ptc Therapeutics (PTCT) Gross Profit (2016 - 2025)
Historic Gross Profit for Ptc Therapeutics (PTCT) over the last 10 years, with Q3 2025 value amounting to $195.2 million.
- Ptc Therapeutics' Gross Profit rose 499.52% to $195.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 16762.96%. This contributed to the annual value of $749.4 million for FY2024, which is 1409.48% down from last year.
- Per Ptc Therapeutics' latest filing, its Gross Profit stood at $195.2 million for Q3 2025, which was up 499.52% from $167.5 million recorded in Q2 2025.
- Over the past 5 years, Ptc Therapeutics' Gross Profit peaked at $1.2 billion during Q1 2025, and registered a low of -$15.5 million during Q2 2024.
- For the 5-year period, Ptc Therapeutics' Gross Profit averaged around $216.9 million, with its median value being $185.9 million (2024).
- In the last 5 years, Ptc Therapeutics' Gross Profit tumbled by 10772.19% in 2024 and then skyrocketed by 117847.62% in 2025.
- Ptc Therapeutics' Gross Profit (Quarter) stood at $155.9 million in 2021, then grew by 0.4% to $156.5 million in 2022, then surged by 77.57% to $277.9 million in 2023, then fell by 29.16% to $196.9 million in 2024, then fell by 0.84% to $195.2 million in 2025.
- Its Gross Profit stands at $195.2 million for Q3 2025, versus $167.5 million for Q2 2025 and $1.2 billion for Q1 2025.